keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UK-383367 是一种有效、选择性的 BMP-1 抑制剂,IC50=44 nM,对其选择性远高于 MMP 1,2,3,9 和 14。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 333 | 现货 | ||
10 mg | ¥ 479 | 现货 | ||
25 mg | ¥ 793 | 现货 | ||
50 mg | 待询 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 375 | 现货 |
产品描述 | UK-383367 is a procollagen C-proteinase inhibitor with IC50 of 44 nM, has excellent selectivity over MMPs. |
靶点活性 | Procollagen C proteinase:44 nM |
体外活性 | UK-383367 is effective at penetrating human skin. [1] UK-383367 inhibits collagen deposition with IC50 of ~2 μM. UK-383367 has modest affinity for all the PDE-4 subtypes PDE-4a, PDE-4b, PDE-4c and PDE-4d with IC50 of 1.8 μM, 1.5 μM, 2.4 μM and 0.9 μM, respectively. [2] UK-383367 is a weakly acidic compound and lipophilic. [3] |
体内活性 | Plasma protein binding values for UK-383367 in rat, dog and human are 95%, 93% and 94%, respectively. UK-383367 following incubation in rat plasma results in the half-life of 49?min. UK-383367 following single intravenous administration (2 mg/kg) to rat results in the plasma clearance of 157?mL min?1?kg?1, the volume of distribution of 12?L kg?1, and an elimination half-life of 0.8? hour. UK-383367 following single intravenous administration (0.5 mg/kg) to dog results in the plasma clearance of 35?mL min?1?kg?1, the volume of distribution of 4.6?L kg?1, and an elimination half-life of 1.5?hours. UK-383367 following oral administration (2 mg/kg) to dog results in Cmax of 110 ng/mL, Tmax of 0.5-1.5 hour and oral bioavilability of 13%. [3] |
别名 | UK 383367 |
分子量 | 324.38 |
分子式 | C15H24N4O4 |
CAS No. | 348622-88-8 |
keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 65 mg/mL (200.38 mM)
DMSO: 65 mg/mL (200.38 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 3.0828 mL | 15.414 mL | 30.828 mL | 77.0701 mL |
5 mM | 0.6166 mL | 3.0828 mL | 6.1656 mL | 15.414 mL | |
10 mM | 0.3083 mL | 1.5414 mL | 3.0828 mL | 7.707 mL | |
20 mM | 0.1541 mL | 0.7707 mL | 1.5414 mL | 3.8535 mL | |
50 mM | 0.0617 mL | 0.3083 mL | 0.6166 mL | 1.5414 mL | |
100 mM | 0.0308 mL | 0.1541 mL | 0.3083 mL | 0.7707 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
UK-383367 348622-88-8 Metabolism Procollagen C Proteinase inhibit Inhibitor UK 383367 UK383367 inhibitor